ClinicalTrials.gg
Sign In

Cholestasis clinical trials

The registry lists 150 studies for Cholestasis across more than 10 countries. 18 are recruiting or about to start. 68 of them are mainly about Cholestasis (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-21. Counting its 5 narrower conditions too, such as Liver Cirrhosis, Biliary: 414 studies, 86 open.

Get an email when these change. Save the Cholestasis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
66
Status unknown
26
Approved for marketing
12
Terminated
10
Recruiting
9
Not yet recruiting
8

Phase

Phase 2
26
Phase 3
25
Phase 1
11
Phase 4
9
Early Phase 1
1

Where

United States
77
United Kingdom
17
Germany
17
France
16
Canada
16
Italy
14

Who runs them

Mirum Pharmaceuticals, Inc. (9) · GlaxoSmithKline (6) · Arbor Research Collaborative for Health (4) · Albireo (3) · University of Aarhus (3) · Children's Hospital Medical Center, Cincinnati (3) · The University of Texas Health Science Center at San Antonio (2) · Baylor College of Medicine (2)

What is being tested here

Drugs under test in Cholestasis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Maralixibat236
Nemolizumab101
Acetylcysteine101
Calcitriol101
Indocyanine Green101
Fish oil triglycerides0514
Fish Oils0514
Linerixibat025
Ursodeoxycholic Acid024
SMOFlipid013

Coming up

1phase 3 study under way
4studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 4

Who these studies take

Of the 9 Cholestasis studies recruiting now, 1 (11%) set no upper age limit and 8 (89%) stop at 75 or younger. 6 (67%) take children under 18. 1 (11%) are for women only and 0 (0%) for men only; 2 (22%) take healthy volunteers.

Recruiting studies that take each age, of 9
AgeWomenMen
104 (44%)4 (44%)
187 (78%)6 (67%)
304 (44%)3 (33%)
404 (44%)3 (33%)
504 (44%)3 (33%)
653 (33%)3 (33%)
753 (33%)3 (33%)
851 (11%)1 (11%)

Across all 150 studies, recruiting or not: 57% stop at 75 or younger and 53% at 65; 55% take children; 5% are for women only and 1% for men only; 13% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Cholestasis studies take

Of 12 phase 3 interventional studies under Cholestasis, half reached primary completion within 38 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 338 mo26–64 · 12 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 150. Browse all 150 → or search them.